NBC Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

NBC Securities’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.8K	Buy	200 +50	+33%	+$2.25K	﹤0.01%	1891
2026 Q2	$6.31K	Buy	+150	New	+$4.78K	﹤0.01%	2020
2025 Q3	–	Sell	-1,000	Closed	-$24K	–	2777
2025 Q2	$24K	Sell	1,000 -375	-27%	-$8.22K	﹤0.01%	1626
2025 Q1	$28K	Buy	1,375 +1,374	+137,400%	+$34.5K	﹤0.01%	1345
2024 Q4	$32	Sell	1 -1,624	-100%	-$40K	﹤0.01%	1102
2024 Q3	$41K	Hold	1,625	–	–	﹤0.01%	1230
2024 Q2	$38K	Hold	1,625	–	–	﹤0.01%	1218
2024 Q1	$46K	Sell	1,625 -1,900	-54%	-$57.1K	﹤0.01%	1155
2023 Q4	$115K	Buy	3,525 +423	+14%	+$11.5K	0.01%	902
2023 Q3	$86K	Buy	+3,102	New	+$101K	0.01%	980

Other funds holding ARKG

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $32.8B AUM 18.62% 1-Year Est. Return

Florin Court Capital London, United Kingdom $97M AUM 40.08% 1-Year Est. Return

NBC Securities's ARKG Position: Q3 2026 in Review

NBC Securities increased its ARK Genomic Revolution ETF (ARKG) stake by 33% in Q3 2026, buying an estimated $2.25K and bringing the position to 200 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1891.

NBC Securities first reported a position in ARKG in Q3 2023 and has held it in 10 quarters since. The position peaked at $115K in Q4 2023. 260 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

NBC Securities held 200 shares of ARK Genomic Revolution ETF worth $10.8K as of Q3 2026.
NBC Securities bought 50 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $2.25K.
ARK Genomic Revolution ETF made up ﹤0.01% of NBC Securities's portfolio in Q3 2026, its #1891 holding.
NBC Securities first reported a position in ARK Genomic Revolution ETF in Q3 2023 and has held it in 10 quarters since.
NBC Securities's ARK Genomic Revolution ETF position peaked at $115K in Q4 2023.
260 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.